However, Werzowa et al. showed that the combination of PI-103 and rapamycin in vitro (in melanoma cells) and in vivo (in a melanoma mouse model), synergistically induced apoptosis and suppressed Akt/S6 protein phosphorylation with superior efficacy against malignant melanoma [104]. This evidence concerns the gene RPS6 and melanoma.